Many companies focus on developing drugs and medical devices that help patients manage diabetes. We asked three Motley Fool healthcare contributors to identify the diabetes stocks that they would recommend investors watch closely in February. Here's why they chose Insulet (NASDAQ: PODD), Lexicon Pharmaceuticals (NASDAQ: LXRX), and Tandem Diabetes Care (NASDAQ: TNDM).
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,